retatrutide dosage phase 2 trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a What is Retatrutide? Key Facts
Description
Originally developed to manage type 2 diabetes, these tablets have shown potential in helping those who are struggling with weight management
The primary analysis was an intention-to-treat analysis
A component of the Gila monsters venoma peptide known as exendin-4is being explored for new treatments for Alzheimers disease, diabetes, and other diseases.
The answer depends on individual metabolism, lifestyle changes, and genetic factorsnot a one-size-fits-all timeline
It highlights common gastrointestinal effects, rare but debated risks, and areas where further long-term safety data are still needed.
Constipation affects 21% of Retatrutide users
